References
- Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113:898–918
- World Health Organization. Obesity: preventing and managing the global epidemic. Report on a WHO consultation. Technical Report Series, No 894. Geneva: World Health Organization. Available at http://whqlibdoc.who.int/trs/WHO_TRS_894.pdf (accessed October 2006).
- Despres JP, Lemieux I, Prud’homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 2001;322:716–20
- Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study. Lancet 2005;366:1640–9
- Han TS, Williams K, Sattar N, et al. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obes Res 2002;10:923–31
- Hoefle G, Saely CH, Aczel S, et al. Impact of total and central obesity on vascular mortality in patients undergoing coronary angiography. Int J Obes (Lond) 2005;29:785–91
- Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998;280:1843–8
- Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000;102:179–84
- Pascot A, Lemieux I, Prud’homme D, et al. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res 2001;42: 2007–14
- National Cholesterol Education Program. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Institutes of Health/National Heart Lung and Blood Institute. Available at www.nhlbi.nih.gov/guidelines/cholesterol (accessed October 2006).
- International Diabetes Federation. Available at http://www.idf.org/webdata/docs/Meta_syndrome_definition.pdf (accessed October 2006).
- Bruckert E, Baccara-Dinet M, McCoy F, Chapman J. High prevalence of low HDL-cholesterol in a pan-European survey of 8545 dyslipidaemic patients. Curr Med Res Opin 2005;21:1927–34
- Bruckert E, Pamphile R, Mc Coy F, André P. Prevalence of low HDL-C in a European cohort of dyslipidaemic patients. Eur Heart J 2005;7(Suppl F): F23–6
- Vague J. La différenciation sexuelle. Facteur determinant des formes de l’obésité. Presse Med 1947;339–41
- Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006;355:763–78
- Hoefle G, Saely CH, Aczel S. Impact of total and central obesity on vascular mortality in patients undergoing coronary angiography. Int J Obes 2005;29:785–91
- Paccaud F, Schluter-Fasmeyer V, Wietlisbach V, Bovet P. Dyslipidemia and abdominal obesity: an assessment in three general populations. J Clin Epidemiol 2000;53:393–400
- Zhu S, Wang Z, Heshka S, et al. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr 2002;76:743–9
- Ascaso JF, Romero P, Real JT, et al. Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. Eur J Intern Med 2003;14:101–6